ArticleOncology letters2023

Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway.

Xiaomei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.